• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Dr Mark R Philips

Mark. R. Philips, MD is Professor of Medicine, Cell Biology and Biochemistry & Molecular Pharmacology, and Associate Director for Basic Science at the NYU Cancer Institute; and Director of the Medical Scientist Training (MD/PhD) Program at the New York University School of Medicine.

Mark Philips is a molecular cell biologist who focuses on the post-translational modification and membrane targeting of small GTPases, especially Ras. His discovery in 1999 that Ras proteins are modified on, and traffic through, internal membranes en route to the plasma membrane had a major impact in the field. He went on to show that Ras can signal from internal membranes and made numerous contributions to our current understanding of Ras modification and trafficking. Current projects in his laboratory include efforts to characterize the effects of phosphorylation on Kras4B, differential trafficking of the two splice variants of Kras, novel cytosolic chaperones for Ras, as well as assay development for Kras membrane association and their application to genome wide RNAi and small compound screening.

Dr. Philips obtained his BA from Harvard (’78) and MD from Columbia College of Physician’s and Surgeons (’82) before coming to NYU/Bellevue to train in Internal Medicine and Rheumatology. He began his exploration of small GTPases in the context of inflammatory cells as a Rheumatology fellow in the laboratory of Gerald Weissmann and obtained further post-doctoral training in Cell Biology with David Sabatini. He opened his own laboratory at NYU in 1991 and has been funded by the NIH continuously since 1993. He rose to the rank of full professor in 2002. He was appointed Associate Director of the NYU Cancer Institute in 2003 and Director of the Medical Scientist Training (MD/PhD) Program in 2011. Dr. Philips is the recipient of the Young Scholar Award from the Arthritis Foundation, the Orlof Award for Biomedical Research, the Burroughs Wellcome Fund Award for Translational Research and the BioAccelerate NYC Prize. He has been elected to the American Society for Clinical Investigation, the American Association of Physicians and the Interurban Clinical Club.

« Professor Dr Emile Voest
Dr Lisa A Carey »

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info